Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
RSV
-
-
Pharma Science & ResearchSanofi Inc.
Nirsevimab first potential immunisation to protect against RSV in infants
by adminby adminSynopsis : Nirsevimab has the potential to offer RSV protection for all infants, with a single dose showing 74.5 percent efficacy in…